Divozilimab (BCD-132) is a humanized monoclonal antibody specifically targeting CD20, a cell surface protein primarily expressed on B lymphocytes. This antibody is utilized extensively in the study of multiple sclerosis, aiding in the exploration of B-cell mediated pathogenesis and potential therapeutic interventions.
Divozilimab (BCD-132) is a humanized monoclonal antibody specifically targeting CD20, a cell surface protein primarily expressed on B lymphocytes. This antibody is utilized extensively in the study of multiple sclerosis, aiding in the exploration of B-cell mediated pathogenesis and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
